Paper31508286
Cytomembrane-Mediated Transport of Metal Ions with Biological Specificity.
Zhang MK and 6 others. Adv Sci (Weinh), 2019. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Cytomembrane-Mediated Transport of Metal Ions with Biological Specificity. Papers, record 31508286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31508286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18548064 | What we can do and what we cannot do with fMRI. | Nature | 2008 | https://conductscience.org/library/papers/18548064 | PubMed |
| 2 | 25600972 | Gold nanoparticles for photoacoustic imaging. | Nanomedicine (Lond) | 2015 | https://conductscience.org/library/papers/25600972 | PubMed |
| 3 | 28654103 | The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. | Chem Soc Rev | 2017 | https://conductscience.org/library/papers/28654103 | PubMed |
| 4 | 14733542 | A general strategy to convert the MerR family proteins into highly sensitive and selective fluorescent biosensors for metal ions. | J Am Chem Soc | 2004 | https://conductscience.org/library/papers/14733542 | PubMed |
| 5 | 19331179 | Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis. | Anticancer Res | 2009 | https://conductscience.org/library/papers/19331179 | PubMed |
| 6 | 22800620 | Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutions. | Adv Drug Deliv Rev | 2012 | https://conductscience.org/library/papers/22800620 | PubMed |
| 7 | 22770569 | Long-circulating Er3+-doped Yb2O3 up-conversion nanoparticle as an in vivo X-Ray CT imaging contrast agent. | Biomaterials | 2012 | https://conductscience.org/library/papers/22770569 | PubMed |
| 8 | 27296269 | Super-resolution fluorescent materials: an insight into design and bioimaging applications. | Chem Soc Rev | 2016 | https://conductscience.org/library/papers/27296269 | PubMed |
| 9 | 15523680 | Catalytic promiscuity in biocatalysis: using old enzymes to form new bonds and follow new pathways. | Angew Chem Int Ed Engl | 2004 | https://conductscience.org/library/papers/15523680 | PubMed |
| 10 | 27628433 | Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors. | Adv Mater | 2016 | https://conductscience.org/library/papers/27628433 | PubMed |
| 11 | 28665106 | Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy. | ACS Nano | 2017 | https://conductscience.org/library/papers/28665106 | PubMed |
| 12 | 24331707 | Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies. | Biomaterials | 2014 | https://conductscience.org/library/papers/24331707 | PubMed |
| 13 | 31508286 | Cytomembrane-Mediated Transport of Metal Ions with Biological Specificity. | Adv Sci (Weinh) | 2019 | https://conductscience.org/library/papers/31508286 | PubMed |
| 14 | 22138852 | Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. | Chem Soc Rev | 2012 | https://conductscience.org/library/papers/22138852 | PubMed |
| 15 | 27467727 | Contrast agents for molecular photoacoustic imaging. | Nat Methods | 2016 | https://conductscience.org/library/papers/27467727 | PubMed |
| 16 | 30624051 | Highly Efficient Fluorescent Material Based on Rare-Earth-Modified Polyhydroxyalkanoates. | Biomacromolecules | 2019 | https://conductscience.org/library/papers/30624051 | PubMed |
| 17 | 20972977 | Templating synthesis of preloaded Doxorubicin in hollow mesoporous silica nanospheres for biomedical applications. | Adv Mater | 2010 | https://conductscience.org/library/papers/20972977 | PubMed |
| 18 | 18844356 | Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. | J Am Chem Soc | 2008 | https://conductscience.org/library/papers/18844356 | PubMed |
| 19 | 15592524 | Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. | Oncogene | 2005 | https://conductscience.org/library/papers/15592524 | PubMed |
| 20 | 28033465 | Diketopyrrolopyrrole-Triphenylamine Organic Nanoparticles as Multifunctional Reagents for Photoacoustic Imaging-Guided Photodynamic/Photothermal Synergistic Tumor Therapy. | ACS Nano | 2017 | https://conductscience.org/library/papers/28033465 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42152975 | Therapeutic Metal Ions: Engineering Biomaterials for Multimodal Disease Treatment. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42152975 | PubMed |
| 41977221 | siRNA Nanoparticle Delivery Strategies and Clinical Trial Advances in Tumor Therapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977221 | PubMed |
| 41322142 | Multifunctional DSF-loaded ICG-chelated nanozyme for four-in-one enhanced synergistic tumor therapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41322142 | PubMed |
| 40066324 | Optimization of Metal-Based Nanoparticle Composite Formulations and Their Application in Wound Dressings. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40066324 | PubMed |
| 39811105 | Homologous-adhering/targeting cell membrane- and cell-mediated delivery systems: a cancer-catch-cancer strategy in cancer therapy. | Regen Biomater | 2025 | https://conductscience.org/library/papers/39811105 | PubMed |
| 38248386 | Engineered Electrochemiluminescence Biosensors for Monitoring Heavy Metal Ions: Current Status and Prospects. | Biosensors (Basel) | 2023 | https://conductscience.org/library/papers/38248386 | PubMed |
| 36277398 | Biomimetic nanomaterial-facilitated oxygen generation strategies for enhancing tumour treatment outcomes. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36277398 | PubMed |
| 36226180 | Cuproptosis patterns and tumor microenvironment in endometrial cancer. | Front Genet | 2022 | https://conductscience.org/library/papers/36226180 | PubMed |
| 35890175 | Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35890175 | PubMed |
| 35784636 | Carrier-free nanoprodrug for p53-mutated tumor therapy via concurrent delivery of zinc-manganese dual ions and ROS. | Bioact Mater | 2023 | https://conductscience.org/library/papers/35784636 | PubMed |
| 34166584 | Biomedical Implants with Charge-Transfer Monitoring and Regulating Abilities. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34166584 | PubMed |
| 32334412 | Intracellular Ca2+ Cascade Guided by NIR-II Photothermal Switch for Specific Tumor Therapy. | iScience | 2020 | https://conductscience.org/library/papers/32334412 | PubMed |
| 31508286 | Cytomembrane-Mediated Transport of Metal Ions with Biological Specificity. | Adv Sci (Weinh) | 2019 | https://conductscience.org/library/papers/31508286 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31508286
GET https://conductscience.org/api/papers/v1/31508286/references?page=2